Chapter 3 Hormonal Influences on Seizures. Basic Neurobiology

International Review of Neurobiology

Volumn 83, Issue , 2008, Pages 27-77

  Frye, Cheryl A ^a  

^a Departments of Psychology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE;

ANIMAL; HUMAN; METABOLISM; NEUROBIOLOGY; PATHOPHYSIOLOGY; REVIEW; SEIZURE; SEXUAL DEVELOPMENT;

ANIMALS; HORMONES; HUMANS; NEUROBIOLOGY; SEIZURES; SEX CHARACTERISTICS;

EID: 53049108463     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(08)00003-2     Document Type: Review

References (356)

1. Abbasi F., Krumholz A., Kittner S.J., and Langenberg P. Effects of menopause on seizures in women with epilepsy. Epilepsia 40 (1999) 205-210
2. Almqvist R. The rhythm of epileptic attacks and its relationship to the menstrual cycle. Acta Psychiatr. Neurol. Scand. Suppl. 105 (1955) 1-116
3. Andersen M.L., Bignotto M., Machado R.B., and Tufik S. Different stress modalities result in distinct steroid hormone responses by male rats. Braz. J. Med. Biol. Res. 37 (2004) 791-797
4. Andersen M.L., Martins P.J., D'Almedia V., Bignotto M., and Tufik S. Endocrinological and catecholaminergic alterations during sleep deprivation and recovery in male rats. J. Sleep Res. 14 (2005) 83-90
5. Andersson S. Steroidogenic enzymes in skin. Eur. J. Dermatol. 4 (2001) 293-295
6. Andréen L., Bixo M., Nyberg S., Sundström-Poromaa I., and Bäckström T. Progesterone effects during sequential hormone replacement therapy. Eur. J. Endocrinol 148 (2003) 571-577
7. Andréen L., Sundström-Poromaa I., Bixo M., Andersson A., Nyberg S., and Bäckström T. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrinology 30 (2005) 212-224
8. Andrews N., Zharkowsky A., and File S.E. Acute stress down regulates benzodiazepine receptors: Reversal by diazepam. Eur. J. Pharmacol. 210 (1992) 247-251
9. Avanzini G., and Marescaux C. Genetic animal models for generalized non convulsive epilepsies and new antiepileptic drugs. Epilepsy Res. Suppl. 3 (1991) 29-38
10. Bäckström T. Epilepsy in women. Oestrogen and progesterone plasma levels. Experientia 32 (1976) 248-249
11. Bäckström T., Carstensen H., and Sodergard R. Concentration of estradiol, testosterone and progesterone in cerebrospinal fluid compared with plasma unbound and total concentrations. J. Steroid Biochem. 7 (1976) 469-472
12. Bäckström T., Zetterlund B., Blom S., and Romano M. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol. Scand. 69 (1984) 240-248
13. Baram T.Z., and Hatalski C.G. Neuropeptide-mediated excitability: A key triggering mechanism for seizure generation in the developing brain. Trends Neurosci. 21 (1998) 471-476
14. Barbaccia M.L., Concas A., Serra M., and Biggio G. Stress and neurosteroids in adult and aged rats. Exp. Gerontol. 33 (1998) 697-712
15. Barbaccia M.L., Serra M., Purdy R.H., and Biggio G. Stress and neuroactive steroids. Int. Rev. Neurobiol. 46 (2001) 243-272
16. Bauer J., Stoffel-Wagner B., Flügel D., Kluge M., Schramm J., Bidlingmaier F., and Elger C.E. Serum androgens return to normal after temporal lobe epilepsy surgery in men. Neurology 55 (2000) 820-824
17. Bauer J., Stoffel-Wagner B., Flugel D., Kluge M., and Elger C.E. The impact of epilepsy surgery on sex hormones and the menstrual cycle in female patients. Seizure 9 (2000) 389-393
18. Baulieu E.E. Neurosteroids: Of the nervous system, by the nervous system, for the nervous system. Recent Prog. Horm. Res. 52 (1997) 1-32
19. Baulieu E.E., and Robel P. Neurosteroids: A new brain function?. J. Steroid Biochem. Mol. Biol. 493 (1990) 395-403
20. Beauchamp M.H., Ormerod B.K., Jhamandas K., Boegman R.J., and Beninger R.J. Neurosteroids and reward: Allopregnano-lone produces a conditioned place aversion in rats. Pharmacol. Biochem. Behav. 67 (2000) 29-35
21. Belelli D., and Herd M.B. The contraceptive agent Provera enhances GABA(A) receptor-mediated inhibitory neurotransmission in the rat hippocampus: Evidence for endogenous neurosteroids. J. Neurosci. 23 (2003) 10013-10020
22. Belelli D., Bolger M.B., and Gee K.W. Anticonvulsant profile of the progesterone metabolite 5 alpha-pregnan-3 alpha-ol-20-one. Eur. J. Pharmacol. 166 (1989) 325-329
23. Berdiev R.K., Chepurnov S.A., Chepurnova N.E., van Luijtelaar E.L.J.M., and Coenen A.M.L. Effects of Neuropeptide Galanin on Spike-Wave Discharges in WAG/Rij Rats. (2000), Nijmegen University Press, Nijmegen 71-78
24. Bernardi F., Salvestroni C., Casarosa E., Nappi R.E., Lanzone A., Luisi S., Purdy R.H., Petraglia F., and Genazzani A.R. Aging is associated with changes in allopregnanolone concentrations in brain, endocrine glands and serum in male rats. Eur. J. Endocrinol. 138 (1998) 316-321
25. Bernardi F., Pieri M., Stomati M., Luisi S., Palumbo M., Pluchino N., Ceccarelli C., and Genazzani A.R. Effect of different hormonal replacement therapies on circulating allopregnano-lone and dehydroepiandrosterone levels in postmenopausal women. Gynecol. Endocrinol. 17 (2003) 65-77
26. Besman M.J., Yanagibashi K., Lee T.D., Kawamura M., Hall P.F., and Shively J.E. Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: Stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc. Natl. Acad. Sci. USA 86 (1989) 4897-4901
27. Bicikova M., Lapcik O., Hampl R., Starka L., Knuppen R., Haupt O., and Dibbelt L. A novel radioimmunoassay of allopregnano-lone. Steroids 60 (1995) 210-213
28. Bickerstaff E. Neurological Complications of Oral Contraceptives (1975), Clarendon Press, Oxford
29. Biggio G. The action of stress, U-carbolines, diazepam and Ro 15-1788 on GABA receptors in the rat brain. Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology (1983), Raven Press, New York, NY 105-117
30. Biggio G., Corda M.G., Dermontis G., Rossetti Z., and Gessa G.L. Sudden decrease in cerebellar GABA binding induced by stress. Pharmacol. Res. Commun. 12 (1980) 489-493
31. Biggio G., Corda M.G., Concas A., Dermontis G., Rossetti Z., and Gessa G.L. Rapid changes in GABA binding induced by stress in different areas of the rat brain. Brain Res. 229 (1981) 363-369
32. Biggio G., Concas A., Mostallino M.C., Purdy R.H., Trabucchi M., and Barbaccia M.L. Inhibition of GABAergic transmission enhances neurosteroid concentrations in the rat brain. The Brain: Source and Target for Sex Steroid Hormones (1996), Informa Healthcare, New York, NY 43-62
33. Biggio G., Barbaccia M.L., Follesa P., Serra M., Purdy R.H., and Concas A. Neurosteroids and GABAA receptor plasticity. GABA in the Nervous System (2000), Lippincott Williams & Wilkins, Philadelphia, PA 207-232
34. Biggio G., Follesa P., Sanna E., Purdy R.H., and Concas A. GABAA-receptor plasticity during long-term exposure to and withdrawal from progesterone. Int. Rev. Neurobiol. 46 (2001) 207-241
35. Bilo L., Meo R., Nappi C., Annunziato L., Striano S., Colao A.M., Merola B., and Buscaino G.A. Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia 29 (1988) 612-619
36. Bilo L., Meo R., Valentino R., Buscaino G.A., Striano S., and Nappi C. Abnormal pattern of luteinizing hormone pulsatility in women with epilepsy. Fertil. Steril. 55 (1991) 705-711
37. Bixo M., Bäckström T., Winblad B., and Andersson A. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J. Steroid Biochem. Mol. Biol. 55 (1995) 297-303
38. Bixo M., Andersson A., Winblad B., Purdy R.H., and Bäckström T. Progesterone, 5alphapregnane-3, 20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res. 764 (1997) 173-178
39. Björn I., Bixo M., Nöjd K.S., Nyberg S., and Bäckström T. Negative mood changes during hormone replacement therapy: A comparison between two progestogens. Am. J. Obstet. Gynecol. 183 (2000) 1419-1426
40. Boulware M.I., Weick J.P., Becklund B.R., Kuo S.P., Groth R.D., and Mermelstein P.G. Estradiol activates group I and II meta-botropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. J. Neurosci. 25 (2005) 5066-5078
41. Brann D.W., Putnam C.D., and Mahesh V.B. Gamma-aminobutyric acidA receptors mediate 3 alpha-hydroxy-5 alpha-pregnan-20-one-induced gonadotropin secretion. Endocrinology 126 (1990) 1854-1859
42. Breedlove S.M., Jacobson C.D., Gorski R.A., and Arnold A.P. Masculinization of the female rat spinal cord following a single injection of testosterone propionate but not estradiol benzoate. Brain Res. 237 1 (1982) 173-181
43. Brown-Grant K., and Raisman G. Reproductive function in the rat following selective destruction of afferent fibres to the hypothalamus from the limbic system. Brain Res. 46 (1972) 23-42
44. Brussaard A.B., and Koksma J.J. Short-term modulation of GABAA receptor function in the adult female rat. Prog. Brain Res. 139 (2002) 31-42
45. Brussaard A.B., Devay P., Leyting-Vermeulen J.L., and Kits K.S. Changes in properties and neurosteroid regulation of GABAergic synapses in the SO nucleus during the mammalian female reproductive cycle. J. Physiol. 516 (1999) 513-524
46. Bruton C.J., Stevens J.R., and Frith C.D. Epilepsy, psychosis, and schizophrenia: Clinical and neuropathologic correlations. Neurology 44 (1994) 34-42
47. Buckmaster P.S., and Dudek F.E. Network properties of the dentate gyrus in epileptic rats with hilar neuron loss and granule cell axon reorganization. J. Neurophysiol. 77 (1997) 2685-2696
48. Budziszewska B., Van Luijtelaar G., Coenen A., Leskiewicz M., and Lason W. Effects of neurosteroids on spike-wave discharges in the genetic epileptic WAG/Rij rat. Epilepsy Res. 33 (1999) 23-29
49. Callies F., Arlt W., Siekmann L., Hubler D., Bidlingmaier F., and Allolio B. Influence of oral dehydroepiandrosterone (DHEA) on urinary steroid metabolites in males and females. Steroids 65 (2000) 98-102
50. Campbell S., and Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin. Obstet. Gynaecol. 4 (1977) 31-47
51. Canonaco M., O'connor L.H., Pfaff D.W., and McEwen B.S. Longer term progesterone treatment induces changes of GABAA receptor levels in forebrain sites in the female hamster: Quantative autoradiography study. Exp. Brain Res. 77 (1989) 407-411
52. Cantor B. Induction of ovulation with clomiphene citrate. In: Sciarri J.J. (Ed). Gynecology and Obstetrics Vol. 5 (1984), Harper and Rowe, Philadelphia, PA 1-7
53. Carl P., Högskilde S., Nielsen J.W., Sörensen M.B., Lindholm M., Karlen B., and Bäckström T. Pregnanolone emulsion. A preliminary pharmacokinetic and pharmacodynamic study of a new intravenous anaesthetic agent. Anaesthesia 45 (1990) 189-197
54. Carrer H.F., Whitmoyer D.I., and Sawyer C.H. Effects of hippocampal and amygdaloid stimulation on the firing of preoptic neurons in the proestrous female rat. Brain Res. 142 (1978) 363-367
55. Cheng Y.J., and Karavolas H.J. Conversion of progesterone to 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one by rat medical basal hypothalami and the effects of estradiol and stage of estrous cycle on the conversion. Endocrinology 93 5 (1973) 1157-1162
56. Coenen A.M.L., Drinkenburg W.H.I.M., Inoue M., and van Luijtelaar E.L.J.M. Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats. Epilepsy Res. 12 (1992) 75-86
57. Concas A., Mele S., and Biggio G. Foot shock stress decreases chloride efflux from rat brain neurosynaptosomes. Eur. J. Pharmacol. 135 (1987) 423-427
58. Concas A., Serra M., Atsoggiu T., and Biggio G. Foot-shock stress and anxiogenic beta-carbolines increase t-[35S]butylbicyclo-phosphorothionate binding in the rat cerebral cortex, an effect opposite to anxiolytics and gamma-aminobutyric acid mi-metics. J. Neurochem. 51 (1988) 1868-1876
59. Concas A., Mostallino M.C., Perra C., Lener R., Roscetti G., Barbaccia M.L., Purdy R.H., and Biggio G. Functional correlation between allopregnanolone and [35 S]TBPS binding in the brain of rats exposed to isoniazid, pentylenete-trazol or stress. Br. J. Pharmacol. 118 (1996) 839-846
60. Concas A., Follesa P., Barbaccia M.L., Purdy R.H., and Biggio G. Physiological modulation of GABA receptor plasticity by progesterone metabolites. Eur. J. Pharmacol. 375 (1999) 225-235
61. Corpechot C., Robel P., Axelson M., Sjövall J., and Baulieu E.E. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. USA 78 (1981) 4704-4707
62. Corpéchot C., Young J., Calvel M., Wehrey C., Veltz J.N., Touyer G., Mouren M., Prasad V.V., Banner C., Sjövall J., et al. Neurosteroids: 3 Alpha-hydroxy-5 alpha-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133 (1993) 1003-1009
63. Costa A.M., Spence K.T., Smith S.S., and French-Mullen J.M. Withdrawal from the endogenous steroid progesterone results in GABAA currents insensitive to benzodiazepine modulation in rats CA1 hippocampus. J. Neurophysiol. 74 (1995) 464-469
64. Covolan L., and Mello L.E. Temporal profile of neuronal injury following pilocarpine or kainic acid-induced status epilepticus. Epilepsy Res. 39 (2000) 133-152
65. Czlonkowska A.I., Krzascik P., Sienkiewicz-Jarosz H., Siemiatkowski M., Szyndler J., Maciejak P., Bidzinski A., and Plaznik A. Tolerance to the anticonvulsant activity of midazolam and allopregnanolone in a model of picrotoxin seizures. Eur. J. Pharmacol. 425 (2001) 121-127
66. Damianisch K., Rupprecht R., and Lancel M. The influence of subchronic administration of the neurosteroid allopregnanolone on sleep in the rat. Neuropsychopharmacology 25 (2001) 576-584
67. Dana-Haeri J., Trimble M., and Oxley J. Prolactin and gonadotrophin changes following generalised and partial seizures. J. Neurol. Neurosurg. Psychiatry 46 (1983) 331-335
68. de Wit H., Schmitt L., Purdy R., and Hauger R. Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women. Psychoneuroendocrinology 26 (2001) 697-710
69. Ditkoff E.C., Crary W.G., Cristo M., and Lobo R.A. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet. Gynecol. 18 (1991) 991-995
70. Drislane F.W., Coleman A.E., Schomer D.L., Ives J., Levesque L.A., Seibel M.M., and Herzog A.G. Altered pulsatile secretion of luteinizing hormone in women with epilepsy. Neurology 44 (1994) 306-310
71. Droogleever Fortuyn H.A., van Broekhoven F., Span P.N., Bäckström T., Zitman F.G., and Verkes R.J. Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor density. Psychoneuroendocrinology 93 (2004) 1341-1344
72. Drugan R.C., Morrow A.L., Weizman R., Weizman A., Deutsch S.I., Crawley J.N., and Paul S.M. Stress-induced behavioural depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancy. Brain Res. 487 (1989) 45-51
73. Duncan S., Blacklaw J., Beastall G.H., and Brodie M.J. Antiepileptic drug therapy and sexual function in men with epilepsy. Epilepsia 40 (1999) 197-204
74. Edwards H.E., Burnham W.M., Mendonca A., Bowlby D.A., and MacLusky N.J. Steroid hormones affect limbic afterdischarge thresholds and kindling rates in adult female rats. Brain Res. 838 (1999) 136-150
75. Edwards H.E., Burnham W.M., Ng M.M., Asa S., and MacLusky N.J. Limbic seizures alter reproductive function in the female rat. Epilepsia 40 (1999) 1370-1377
76. Edwards H.E., Dortok D., Tam J., Won D., and Burnham W.M. Prenatal stress alters seizure thresholds and the development of kindled seizures in infant and adult rats. Horm. Behav. 42 (2002) 437-447
77. el-Etr M., Akwa Y., Fiddes R.J., Robel P., and Baulieu E.E. A progesterone metabolite stimulates the release of gonadotropin-releasing hormone from GT1-1 hypothalamic neurons via the gammaaminobutyric acid type A receptor. Proc. Natl. Acad. Sci. USA 92 (1995) 3769-3773
78. English J.D., and Sweatt J.D. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J. Biol. Chem. 272 (1997) 19103-19106
79. Erskine M.S., and Kornberg E. Stress and ACTH increase circulating concentrations of 3 alpha-androstanediol in female rats. Life Sci. 51 (1992) 2065-2071
80. Everett J.W. Pituitary and hypothalamus: Perspectives and overview. The Physiology of Reproduction (1994), Academic Press, London, New York, and San Diego 1509-1526
81. Fenoglio K.A., Brunson K.L., and Baram T.Z. ippocampal neuroplasticity induced by early-life stress: Functional and molecular aspects. Front. Neuroendocrinol. 27 (2006) 180-192
82. File S.E., Zangrossi H., and Andrews N. Novel environment and cat odor change GABA and 5HT release and uptake in the rat. Pharmacol. Biochem. Behav. 45 (1993) 931-934
83. Fish E.W., Faccidomo S., DeBold J.F., and Miczek K.A. Alcohol, allopregnanolone and aggression in mice. Psychopharmacology (Berl) 153 (2001) 473-843
84. Follesa P., Serra M., Cagetti E., Pisu M.G., Porta S., Floris S., Massa F., Sanna E., and Biggio G. Allopregnanolone synthesis in cerebellar granule cells: Roles in regulation of GABAA receptor expression and function during progesterone treatment and withdrawal. Mol. Pharmacol. 57 (2000) 1262-1270
85. Follesa P., Porcu P., Sogliano C., Cinus M., Biggio F., Mancuso L., Mostallino M.C., Paoletti A.M., Purdy R.H., Biggio G., and Concas A. Changes in GABAA receptor gamma 2 subunit gene expression induced by long-term administration of oral contraceptives in rats. Neuropharmacology 42 (2002) 325-336
86. Friedman M.N., Geula C., Holmes G.L., and Herzog A.G. GnRH-immunoreactive fiber changes with unilateral amygdala-kindled seizures. Epilepsy Res. 52 (2002) 73-77
87. Frisone D.F., Frye C.A., and Zimmerberg B. Social isolation stress during the third week of life has age-dependent effects on spatial learning in rats. Behav. Brain Res. 128 (2002) 153-160
88. Frye C.A. Ovarian hormones: Their effects on cortical excitation and influences on epileptogenesis. In: Harden C.L. (Ed). Epilepsy and Ovarian Hormones (2005) Part 1 of the Epilepsy and Female Reproductive Milestones: Topics Spanning a Lifetime series, Neurology 64 (9): [CD E-sert]. CME: Emory University; Release Date: May 2005; End Date: May 31, 2008
89. Frye C.A. Role of androgens in epilepsy. Expert Rev. Neurother. 6 (2006) 1061-1075
90. Frye C.A., and Bayon L.E. Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3 alpha,5 alpha-THP. Neuroendocrinology 68 (1998) 272-280 Erratum in: Neuroendocrinology 68, 436
91. Frye C.A., and Bayon L.E. Increased seizure activity following precipitous decline in endogenous 3α,5α-THP. Neuroendocrinology 68 (1998) 272-280
92. Frye C.A., and Bayon L.E. Prenatal stress reduces the effectiveness of the neurosteroid 3 alpha,5 alpha-THP to block kainic-acid-induced seizures. Dev. Psychobiol. 34 (1999) 227-234
93. Frye C.A., and Bayon L.E. Mating stimuli influence endogenous variations in the neurosteroids 3alpha,5alpha-THP and 3alpha-Diol. J. Neuroendocrinol. 11 (1999) 839-847
94. Frye C.A., and Bayon L.E. Cyclic withdrawal from endogenous and exogenous progesterone increases kainic acid and perforant pathway induced seizures. Pharmacol. Biochem. Behav. 62 2 (1999) 315-321
95. Frye C.A., and Orecki Z.A. Prenatal stress alters reproductive responses of rats in behavioral estrus and paced mating of hormone-primed rats. Horm. Behav. 42 (2002) 472-483
96. Frye C.A., and Orecki Z.A. Prenatal stress produces deficits in socio-sexual behavior of cycling, but not hormone-primed, Long-Evans rats. Pharmacol. Biochem. Behav. 3 (2002) 53-60
97. Frye C.A., and Reed T.A. Androgenic neurosteroids: Anti-seizure effects in an animal model of epilepsy. Psychoneuroendocrinology 23 (1998) 385-399
98. Frye C.A., and Rhodes M.E. Estrogen-priming can enhance progesterone's anti-seizure effects in part by increasing hippocampal levels of allopregnanolone. Pharmacol. Biochem. Behav. 81 (2005) 907-916
99. Frye C.A., and Rhodes M.E. Infusions of 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP) to the ventral tegmental area, but not the substantia nigra, enhance exploratory, anti-anxiety, social and sexual behaviours and concomitantly increase 3alpha,5alpha-THP concentrations in the hippocampus, diencephalon and cortex of ovariectomised oestrogen-primed rats. J. Neuroendocrinol 18 12 (2006) 960-975
100. Frye C.A., Rhodes M.E., Walf A., and Harney J. Progesterone reduces pentylenetetrazolinducedictal activity of wild-type mice but not those deficient in type I 5alpha-reductase. Epilepsia 43 43 Suppl (2002) 14-17
101. Frye C.A., and Scalise T.J. Anti-seizure effects of progesterone and 3 á,5 á-THP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology 25 (2000) 407-420
102. Frye C.A., and Wawrzycki J. Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats. Horm. Behav. 44 (2003) 319-326
103. Frye C.A., Duncan J.E., Basham M., and Erskine M.S. Behavioral effects of 3 alpha-androstanediol. II: Hypothalamic and preoptic area actions via a GABAergic mechanism. Behav. Brain Res. 79 (1996) 119-130
104. Frye C.A., McCormick C.M., Coopersmith C., and Erskine M.S. Effects of paced and non-paced mating stimulation on plasma progesterone, 3 alpha-diol and corticosterone. Psychoneuroendocrinology 21 (1996) 431-439
105. Frye C.A., Van Keuren K.R., and Erskine M.S. Behavioral effects of 3 alpha-androstanediol. I: Modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behav. Brain Res. 79 (1996) 109-118
106. Frye C.A., Van Keuren K.R., Rao P.N., and Erskine M.S. Analgesic effects of the neurosteroid 3 alpha-androstanediol. Brain Res. 709 (1996) 1-9
107. Frye C.A., Van Keuren K.R., Rao P.N., and Erskine M.S. Progesterone and 3 alpha-androstanediol conjugated to bovine serum albumin affects estrous behavior when applied to the MBH and POA. Behav. Neurosci. 110 (1996) 603-612
108. Frye C.A., Scalise T., and Bayon L.E. Finasteride blocks the reduction in ictal activity produced by exogenous estrous cyclicity. J. Neuroendocrin. 10 (1998) 291-296
109. Frye C.A. The neurosteroid 3 alpha, 5 alpha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 696 1-2 (1995) 113-120
110. Frye C.A., Rhodes M.E., Petralia S.M., Walf A.A., Sumida K., and Edinger K.L. 3alpha-hydroxy-5alpha-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviors. Neuroscience 138 (2006) 1007-1014
111. Frye C.A., Rhodes M.E., Raol Y.H., and Brooks-Kayal A.R. Early postnatal stimulation alters pregnane neurosteroids in the hippocampus. Psychopharmacology (Berl) 186 (2006) 343-350
112. Fujikawa D.G. The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus. Brain Res. 725 (1996) 11-22
113. Galanopoulou A.S., Kyrozis A., Claudio O.I., Stanton P.K., and Moshé S.L. Sex-specific KCC2 expression and GABA(A) receptor function in rat substantia nigra. Exp. Neurol. 183 (2003) 628-637
114. Galanopoulou A.S., Alm E.M., and Velíšková J. Estradiol reduces seizure-induced hippocampal injury in ovariectomized female but not in male rats. Neurosci. Lett. 342 (2003) 201-205
115. Gavish M., Weizman A., Moussa B.H., Okun Y., and Okun F. Regulation of central and peripheral benzodiazepinee receptors in progesterone-treated rats. Brain Res. 409 (1987) 386-390
116. Gee K.W. Steroid modulation of the GABA/benzodiazepine receptor-linked chloride ionophore. Mol. Neurobiol. 2 (1988) 291-317
117. A receptor complex: The pharmacological properties and therapeutic potential of epalons. Crit. Rev. Neurobiol. 9 (1995) 207-227
118. Genazzani A.R., Palumbo M.A., de Micheroux A.A., Artini P.G., Criscuolo M., Ficarra G., Guo A.L., Benelli A., Bertolini A., Petraglia F., et al. Evidence for a role for the neurosteroid allopregnanolone in the modulation of reproductive function in female rats. Eur. J. Endocrinol. 133 3 (1995) 375-380
119. Genazzani A.R., Petraglia F., Bernardi F., Casarosa E., Salvestroni C., Tonetti A., Nappi R.E., Luisi S., Palumbo M., Purdy R.H., and Luisi M. Circulating levels of allopregnanolone in humans: Gender, age, and endocrine influences. J. Clin. Endocrinol. Metab. 83 6 (1998) 2099-2103
120. Genazzani A.R., Bernardi F., Stomati M., Monteleone P., Luisi S., Rubino S., Farzati A., Casarosa E., Luisi M., and Petraglia F. Effects of estradiol and ealoxifene analog on brain, adrenal and serum allopregnanolone content in fertile and ovariectomized female rats. Neuroendocrinology 72 (2000) 162-170
121. Genazzani A.D., Luisi M., Malavasi B., Strucchi C., Luisi S., Casarosa E., Bernardi F., Genazzani A.R., and Petraglia F. Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects. Eur. J. Endocrinol. 146 (2002) 347-356
122. Giorgi F.S., Velíšková J., Chudomel O., Kyrozis A., and Moshé S.L. The role of substantia nigra pars reticulata in modulating clonic seizures is determined by testosterone levels during the immediate postnatal period. Neurobiol Dis. 25 (2006) 73-79
123. Girdler S., Straneva P., Light K., Pedersen C., and Morrow L. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol. Psychiatry 49 (2001) 788-797
124. Glass M., and Dragunow M. Neurochemical and morphological changes associated with human epilepsy. Brain Res. Brain Res. Rev. 21 1 (1995) 29-41
125. Gloor P., Pellegrini A., and Kostopoulos G.K. Effects of changes in cortical excitability upon the epileptic bursts in generalized penicillin epilepsy of the cat. Electroencephalogr. Clin. Neurophysiol. 46 (1979) 274-289
126. Goldman L., Winget C., Hollingshead G.W., and Levine S. Postweaning development of negative feedback in the pituitary-adrenal system of the rat. Neuroendocrinology 12 (1973) 199-211
127. Gore A.C., and Terasawa E. Neural circuits regulating pulsatile luteinizing hormone release in the female guinea-pig: Opioid, adrenergic and serotonergic interactions. J. Neuroendocrinol. 13 3 (2001) 239-248
128. Gowers W.R. Epilepsy and other Chronic Convulsive Diseases (1881), J. A. Churchill, London
129. Grisham W., Lee J., McCormick M.E., Yang-Stayner K., and Arnold A.P. Antiandrogen blocks estrogen-induced masculinization of the song system in female zebra finches. J. Neurobiol. 51 (2002) 1-8
130. Grunewald R.A., Aliberti V., and Panayiotopoulos C.P. Exacerbation of typical absence seizures by progesterone. Seizure 1 (1992) 137-138
131. Gulinello M., Gong Q.H., Li X., and Smith S.S. Short-term exposure to a neuroactive-steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat. Brain Res. 910 1-2 (2001) 55-66
132. Hagihara K., Hirata S., Osada T., Hirai M., and Kato J. Distribution of cells containing progesterone receptor mRNA in the female rat di- and telencephalon: An in situ hybridization study. Brain Res. Mol. Brain Res. 14 (1992) 239-249
133. Hall S.M. Treatment of menstrual epilepsy with a progesterone-only oral contraceptive. Epilepsia 18 (1977) 235-236
134. Harden C.L., Pulver M.C., Ravdin L., and Jacobs A.R. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 40 (1999) 1402-1407
135. Hauser W.A., Annegers J.F., and Kurland L.T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 34 (1993) 453-468
136. Hawkinson J.E., Kimbrough C.L., Belelli D., Lambert J.J., Purdy R.H., and Lan N.C. Correlation of neuroactive steroid modulation of [35 S]t-butylbicyclophosphorothionate and [3 H]flunitrazepam binding and ã -aminobutyric acidA receptor function. Mol. Pharmacol. 46 (1994) 977-985
137. Hedblom E., and Kirkness E.F. A novel class of GABA receptor A subunit in tissues of the reproductive system. J. Biol. Chem. 272 (1997) 15346-15350
138. Herzog A.G. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology 36 12 (1986) 1607-1610
139. Herzog A.G. Clomiphene therapy in epileptic women with menstrual disorders. Neurology 38 (1988) 432-434
140. Herzog A.G. Reproductive endocrine considerations and hormonal therapy for men with epilepsy. Epilepsia 32 6 (1991) 34-37
141. Herzog A.G. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 45 (1995) 1660-1662
142. Herzog A.G., Seibel M.M., Schomer D.L., Vaitukaitis J.L., and Geschwind N. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch. Neurol. 43 4 (1986) 341-346
143. Herzog A.G., Drislane F.W., Schomer D.L., Levesque L.A., Ives J., Blume H.W., Dubuisson D., and Cosgrove G.R. Abnormal pulsatile secretion of luteinizing hormone in men with epilepsy: Relationship to laterality and nature of paroxysmal discharges. Neurology 40 10 (1990) 1557-1561
144. Heroz A.G., Levesque L.A., Drislane F.W., Ronthal M., and Schomer D.L. Phenytoin-induced elevation of serum estradiol and reproductive dysfunction in men with epilepsy. Epilepsia 32 4 (1991) 550-553
145. Herzog A.G., Klein P., and Ransil B.J. Three patterns of catamenial epilepsy. Epilepsia 38 (1997) 1082-1088
146. Herzog A.G., Klein P., and Jacobs A.R. Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism. Neurology 50 (1998) 782-784
147. Herzog A.G., Coleman A.E., Jacobs A.R., Klein P., Friedman M.N., Drislane F.W., and Schomer D.L. Relationship of sexual dysfunction to epilepsy laterality and reproductive hormone levels in women. Epilepsy Behav. 4 4 (2003) 407-413
148. Herzog A.G., Drislane F.W., Schomer D.L., Pennell P.B., Bromfield E.B., Kelly K.M., Farina E.L., and Frye C.A. Differential effects of antiepileptic drugs on sexual function and reproductive hormones in men with epilepsy: Interim analysis of a comparison between lamotrigine and enzyme-inducing antiepileptic drugs. Epilepsia 45 7 (2004) 764-768
149. Herzog A.G., Harden C.L., Liporace J., Pennell P., Schomer D.L., Sperling M., Fowler K., Nikolov B., Shuman S., and Newman M. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann. Neurol. 56 (2004) 431-434
150. Herzog A.G., Drislane F.W., Schomer D.L., Pennell P.B., Bromfield E.B., Dworetzky B.A., Farina E.L., and Frye C.A. Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. Neurology 65 7 (2005) 1016-1020
151. Herzog A.G., Drislane F.W., Schomer D.L., Pennell P.B., Bromfield E.B., Dworetzky B.A., Farina E.L., and Frye C.A. Differential effects of antiepileptic drugs on neuroactive steroids in men with epilepsy. Epilepsia 47 11 (2006) 1945-1948
152. Hevers W., and Luddens H. The diversity of GABAA receptors: Pharmacological and electrophysiological properties of GABAA channel subtypes. Mol. Neurobiol. 18 (1998) 35-86
153. Hill M., Bicikova M., Parizek A., Havlikova H., Klak J., Fajt T., Meloun M., Cibula D., Cegan A., Sulcova J., Hampl R., and Starka L. Neuroactive-steroids, their precursors and polar conjugates during parturition and postpartum in maternal blood: 2. Time profiles of pregnanolone isomers. J. Steroid Biochem. Mol. Biol. 78 1 (2001) 51-57
154. Hoffman G.E., Moore N., Fiskum G., and Murphy A.Z. Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp. Neurol. 182 (2003) 124-134
155. Hom A.C., and Buterbaugh G.G. Estrogen alters the acquisition of seizures kindled by repeated amygdala stimulation or pentylenetetrazol administration in ovariectomized female rats. Epilepsia 27 (1986) 103-108
156. Hong J.S., McGinty J.F., Grimes L., Kanamatsu T., Obie J., and Mitchell C.L. Seizure-induced alterations in the metabolism of hippocampal opioid peptides suggest opioid modulation of seizure-related behaviors. NIDA Res. Monogr. 82 (1988) 48-66
157. Hoppe U., Holterhus P.M., Wunsch L., Jocham D., Drechsler T., Thiele S., Marschke C., and Hiort O. Tissue-specific transcription profiles of sex steroid biosynthesis enzymes and the androgen receptor. J. Mol. Med. 84 8 (2006) 651-659
158. Hu M.C., Hsu H.J., Guo I.C., and Chung B.C. Function of CYP11A1 in animal models. Mol. Cell. Endocrinol. 215 1-2 (2004) 95-100
159. Huang L.T., Holmes G.L., Lai M.C., Hung P.L., Wang C.L., Wang T.J., Yang C.H., Liou C.W., and Yang S.N. Maternal deprivation stress exacerbates cognitive deficits in immature rats with recurrent seizures. Epilepsia 43 (2002) 1141-1148
160. Iadarola M.J., and Gale K. Cellular compartments of GABA in brain and their relationship to anticonvulsant activity. Mol. Cell. Biochem. 39 (1981) 305-330
161. Ing N.H. Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biol. Reprod. 72 6 (2005) 1290-1296
162. Isojarvi J.I., Pakarinen A.J., and Myllyla V.V. Effects of carbamazepine on the hypothalamic-pituitary-gonadal axis in male patients with epilepsy: A prospective study. Epilepsia 30 (1989) 446-452
163. Isojarvi J.I., Repo M., Pakarinen A.J., Lukkarinen O., and Myllyla V.V. Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy. Epilepsia 36 (1995) 366-370
164. Isojärvi J.I., Löfgren E., Juntunen K.S., Pakarinen A.J., Päivänsalo M., Rautakorpi I., and Tuomivaara L. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology 62 2 (2004) 247-253
165. Jorge-Rivera J.C., McIntyre K.L., and Henderson L.P. Anabolic steroids induce region- and subunit-specific rapid modulation of GABA(A) receptor-mediated currents in the rat forebrain. J. Neurophysiol. 83 (2000) 3299-3309
166. Kalkbrenner K.A., and Standley C.A. Estrogen modulation of NMDA-induced seizures in ovariectomized and non-ovariectomized rats. Brain Res. 964 (2003) 244-249
167. Kawakami M., and Terasawa E. Acute effect of neural deafferentation on timing of gonadotropin secretion before proestrus in the female rat. Endocrinol. Jpn. 19 5 (1972) 449-459
168. Kim J.S., Kim H.Y., Kim J.H., Shin H.K., Lee S.H., Lee Y.S., and Son H. Enhancement of rat hippocampal long-term potentiation by 17 beta-estradiol i nvolves mitogen-activated protein kinase-dependent and -independent components. Neurosci. Lett. 332 (2002) 65-69
169. Klein P., Van Passel-Clark L.M., and Pezzullo J.C. Onset of epilepsy at the time of menarche. Neurology 60 (2003) 495-497
170. Knight A.H., and Rhind E.G. Epilepsy and pregnancy: A study of 153 pregnancies in 59 patients. Epilepsia 16 (1975) 99-110
171. Kobayashi M., and Buckmaster P.S. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J. Neurosci. 23 6 (2003) 2440-2452
172. Kokate T.G., Svensson B.E., and Rogawski M.A. Anticonvulsant activity of neurosteroids: Correlation with ã-aminobutyric acid-evoked chloride current potentiation. J. Pharmacol. Exp. Ther. 270 (1994) 1223-1229
173. Kokate T.G., Cohen A.L., Karp E., and Rogawski M.A. Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacology 35 (1996) 1049-1056
174. Kokate T.G., Banks M.K., Magee T., Yamaguchi S., and Rogawski M.A. Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J. Pharmacol. Exp. Ther. 288 2 (1999) 679-684
175. Kostopoulos G. Spike and wave discharges of absence seizures as a transformation of sleep spindles: The continuing development of a hypothesis. Clin. Neurophysiol. 111 S2 (2000) 27-38
176. Krueger K.E., and Papadopoulos V. Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. J. Biol. Chem. 265 (1990) 15015-15022
177. Lai M.C., Holmes G.L., Lee K.H., Yang S.N., Wang C.A., Wu C.L., Tiao M.M., Hsieh C.S., Lee C.H., and Huang L.T. Effect of neonatal isolation on outcome following neonatal seizures in rats-the role of corticosterone. Epilepsy Res. 68 2 (2006) 123-136
178. Laidlaw J. Catamenial epilepsy. Lancet 2 (1956) 1235-1237
179. Lan N.C., Bolger M.B., and Gee K.W. Identification and characterization of a pregnane steroid recognition site that is functionally coupled to an expressed GABAA receptor. Neurochem Res. 16 (1991) 347-356
180. Landgren S., Bäckström T., and Kalistratov G. The effect of progesterone on the spontaneous interictal spike evoked `by the application of penicillin to the cat's cerebral cortex. J. Neurol. Sci. 36 (1978) 119-133
181. Lason W., Przewlocka B., Coenen A., Przewlocki R., and Van Luijtelaar G. Effects of mu and delta opioid receptor agonists and antagonists on absence epilepsy in WAG/Rij rats. Neuropharmacology 33 2 (1994) 161-166
182. Lennox W.G., and Lennox M.A. Chapter 19: Sympathetic seizures. Epilepsy and Related Disorders. Vol. 2 (1960), Little Brown, Boston, MA 638-658
183. Leranth C., Petnehazy O., and MacLusky N.J. Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J. Neurosci. 23 (2003) 1588-1592
184. Levine J.E., and Ramirez V.D. Luteinizing hormone-releasing hormone release during the rat estrous cycle and after ovariectomy, as estimated with push-pull cannulae. Endocrinology 111 (1982) 1439
185. Levita L., Hammack S.E., Mania I., Li X.Y., Davis M., and Rainnie D.G. 5-hydroxytryptamine1A-like receptor activation in the bed nucleus of the stria terminalis: Electrophysiological and behavioral studies. Neuroscience 128 (2004) 583-596
186. Locock C. Discussion of paper by EH Sieveking. Analysis of cases of epilepsy observed by the author. Lancet 1 52 (1857) 527-528
187. Logothetis J., and Harner R. Electrocortical activation by estrogens. Arch. Neurol. 3 (1960) 290-297
188. Logothetis J., Harner R., Morrell F., et al. The role of estrogens in catamenial exacerbation of epilepsy. Neurology (Minneap) 9 (1958) 352-360
189. Logothetis J., Harner R., Morrel F., and Torres F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology 9 5 (1959) 352-360
190. Lothman E.W., Bertram E.H., 3rd., and Stringer J.L. Functional anatomy of hippocampal seizures. Prog. Neurobiol. 37 (1991) 1-82
191. Luisi S., Petraglia F., Benedetto C., Nappi R.E., Bernardi F., Fadalti M., Reis F.M., Luisi M., and Genazzani A.R. Serum allopregnanolone levels in pregnant women: Changes during pregnancy, at delivery, and in hypertensive patients. J. Clin. Endocrinol. Metab. 85 7 (2000) 2429-2433
192. MacLennan A., Lester S., and Moore V. Oral oestrogen re-placement therapy versus placebo for hot flushes. Cochrane Database Syst. Rev. 1 (2001) CD002978
193. Macphee G.J., Larkin J.G., Butler E., Beastall G.H., and Brodie M.J. Circulating hormones and pituitary responsiveness in young epileptic men receiving long-term antiepileptic medication. Epilepsia 29 4 (1988) 468-475
194. Mahendroo M.S., Cala K.M., Landrum D.P., and Russell D.W. Fetal death in mice lacking 5alpha-Reductase type 1 caused by estrogen excess. Mol. Endocrinol. 11 (1997) 917-927
195. Majewska M.D. Neurosteroids: Endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38 (1992) 379-395
196. Malendowicz L.K. Sex differences in adrenocortical structure and function. III. The effects of postpubertal gonadectomy and gonadal hormone replacement on adrenal cholesterol sidechain cleavage activity and on steroids biosynthesis by rat adrenal homogenates. Endokrinologie 67 (1976) 26-35
197. Marcus E.M., Watson C.W., and Goldman P.L. Effects of steroids on cerebral electrical activity. Arch. Neurol. 15 (1966) 521-532
198. Margerison J.H., and Corsellis J.A. Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 89 (1966) 499-530
199. Marshall F.H., Stratton S.C., Mullings J., Ford E., Worton S.P., Oakley N.R., and Hagan R.M. Development of tolerance in mice to the sedative effects of the neuroactive steroid minaxolone following chronic exposure. Pharmacol. Biochem. Behav. 58 (1997) 1-8
200. Martin I.L., and Dunn S.M.J. GABA receptors. Review written on request by Tocris (2002). www.tocris.com
201. Marx C.E., VanDoren M.J., Duncan G.E., Lieberman J.A., and Morrow A.L. Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. Neuropsychopharmacology 28 (2003) 1-13
202. Masia S.L., Perrine K., Westbrook L., Alper K., and Devinsky O. Emotional outbursts and posttraumatic stress disorder during intracarotid amobarbital procedure. Neurology 54 (2000) 1691-1693
203. Mattson R.H., and Cramer J.A. Epilepsy, sex hormones and antiepileptic drugs. Epilepsia 26 (1985) S40-S51
204. Mattson R.H., Cramer J.A., and Caldwell B.V. Seizure frequency and the menstrual cycle: A clinical study. Epilepsia 22 (1981) 242
205. Mattson R.H., Cramer J.A., Caldwell B.V., and Siconolfi B.C. Treatment of seizures with medroxyprogesterone acetate: Preliminary report. Neurology 34 (1984) 1255-1258
206. McCarthy M.M., and Konkle A.T. When is a sex difference not a sex difference. Front. Neuroendocrinol. 26 (2005) 85-102
207. McCarthy M.M., Felzenberg E., Robbins A., Pfaff D.W., and Schwartz-Giblin S. Infusions of diazepam and allopregnanolone into the midbrain central gray facilitate open-field behavior and sexual receptivity in female rats. Horm. Behav. 29 (1995) 279-295
208. McEwen B.S., and Woolley C.S. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp. Gerontol. 29 (1994) 431-436
209. McNamara J.O. Cellular and molecular basis of epilepsy. J. Neurosci. 14 (1994) 3413-3425
210. Medina J.H., Novas M.L., Wolfman C.N., Levi de Stein M., and De Robertis E. Benzodiazepine receptors in rat cerebral cortex and hippocampus undergo rapid and reversible changes alter acute stress. Neuroscience 9 (1983) 331-335
211. Meeren H.K., Pijn J.P., Van Luijtelaar E.L., Coenen A.M., and Lopes da Silva F.H. Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats. J. Neurosci. 22 (2002) 1480-1495
212. A receptors. Brain Res. Rev. 29 (1999) 196-217
213. Mejias-Aponte C.A., Jimenez-Rivera C.A., and Segarra A.C. Sex differences in models of temporal lobe epilepsy: Role of testosterone. Brain Res. 944 (2002) 210-218
214. Melcangi R.C., and Panzica C. Steroids in the nervous system: Pandora's box?. Trends Neurosci. 24 (2001) 311-312
215. Melcangi R.C., Poletti A., Cavarretta I., Celotti F., Colciago A., Magnaghi V., Motta M., Negri-Cesi P., and Martini L. The 5α-reductase in the central nervous system: Expression and modes of control. J. Steroid Biochem. Mol. Biol. 65 (1998) 295-299
216. Mellon S.H. Neurosteroids: Biochemistry, modes of action, and clinical relevance. J. Clin. Endocrinol. Metab. 78 (1994) 1003-1008
217. Meo R., Bilo L., Nappi C., Tommaselli A.P., Valentino R., Nocerino C., Striano S., and Buscaino G.A. Derangement of the hypothalamic GnRH pulse generator in women with epilepsy. Seizure 2 (1993) 241-252
218. Meyer G., Ferres-Torres R., and Mas M. The effects of puberty and castration on hippocampal dendritic spines of mice. A Golgi study. Brain Res. 155 (1978) 108-112
219. A-benzodiazepine receptor complex, and aggression. Recent Dev. Alcohol. 13 (1997) 139-171
220. A receptors, and escalated aggressive behavior. Horm. Behav. 44 (2003) 242-257
221. Mirescu C., Peters J.D., and Gould E. Early life experience alters response of adult neurogenesis to stress. Nat. Neurosci. 7 (2004) 841-846
222. Mormède P., Courvoisier H., Ramos A., Marissal-Arvy N., Ousova O., Desautes C., Duclos M., Chaouloff F., and Moisan M.P. Molecular genetic approaches to investigate individual variations in behavioral and neuroendocrine stress responses. Psychoneuroendocrinology 27 (2002) 563-583
223. Morrell M.J. Epilepsy and women: The science of why it is special. Neurology 53 (1999) 42-47
224. Morrell M.J. Reproductive and metabolic disorders in women with epilepsy. Epilepsia 44 (2003) 11-20
225. Morrell M.J., Flynn K.L., Seale C.G., Done S., Paulson A.J., Flaster E.R., and Ferin M. Reproductive dysfunction in women with epilepsy: Antiepileptic drug effects on sex-steroid hormones. CNS Spectr. 6 (2001) 771-786
226. Moses-Kolko E.L., Berga S.L., Greer P.J., Smith G., Cidis Meltzer C., and Drevets W.C. Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women. Fertil. Steril. 80 (2003) 554-911
227. Moshé S.L., Sperber E.F., Brown L.L., and Tempel A. Age-dependent changes in substantia nigra GABA-mediated seizure suppression. Epilepsy Res. Suppl. 8 (1992) 97-106
228. Mukhin A.G., Papadopoulos V., Costa E., and Krueger K.E. Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc. Natl. Acad. Sci. USA 86 (1989) 9813-9816
229. Murialdo G., Galimberti C.A., Fonzi S., Manni R., Costelli P., Parodi C., Torre F., Solinas G.P., Polleri A., and Tartara A. Sex hormones, gonadotropins and prolactin in male epileptic subjects in remission: Role of the epileptic syndrome and of antiepileptic drugs. Neuropsychobiology 30 (1994) 29-36
230. Murialdo G., Galimberti C.A., Fonzi S., Manni R., Costelli P., Parodi C., Solinas G.P., Amoretti G., and Tartara A. Sex hormones and pituitary function in male epileptic patients with altered or normal sexuality. Epilepsia 36 4 (1995) 360-365
231. Negro-Vilar A., Ojeda S.A., and McCann S. Catecholaminegric modulation of luteinizing hormone-releasing hormone release by median eminence terminals in vitro. Endocrinology 104 (1979) 1749-1757
232. Newmark N.E., and Penry J.K. Catamenial epilepsy: A review. Epilepsia 21 (1980) 281-300
233. Nicoletti F., Speciale C., Sortino M.A., Summa G., Caruso G., Patti F., and Canonico P.L. Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia 26 (1985) 252-257
234. Norberg L., Wahlström G., and Bäckström T. The anaesthetic potency of 3 alpha-hydroxy-5 alphapregnan-20-one and 3 alpha-hydroxy-5 beta-pregnan-20-one determined with an intravenous EEG threshold method in male rats. Pharmacol. Toxicol. 61 (1987) 42-47
235. Ojeda S., Nego-Vilar A., and McCann S. Evidence for involvement of a-adrenergic receptors in norepinephrine induced prostaglandin E2 and luteinizing hormone-releasing hormone release from the median eminence. Endocrinology 110 (1982) 409-412
236. Osterlund M.K., and Hurd Y.L. Acute 17 beta-estradiol treatment down-regulates serotonin 5HT1A receptor mRNA expression in the limbic system of female rats. Brain Res. Mol. Brain Res. 55 (1998) 169-172
237. Osterlund M.K., Grandien K., Keller E., and Hurd Y.L. The human brain has distinct regional expression patterns of estrogen receptor alpha mRNA isoforms derived from alternative promoters. J. Neurochem. 75 4 (2000) 1390-1397
238. Osterlund M.K., Gustafsson J.A., Keller E., and Hurd Y.L. Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: Distinct distribution pattern to ERalpha mRNA. J. Clin. Endocrinol. Metab. 85 10 (2000) 3840-3846
239. Ottander U., Sundström Poromaa I., Bjurulf E., Skytt A., Bäckström T., and Olofsson J.I. Allopregnanolone and pregnanolone are produced by the human corpus luteum. Mol. Cell. Endocrinol. 239 (2005) 37-44
240. Pfaff D.W., Gerlach J.L., McEwen B.S., Ferin M., Carmel P., and Zimmerman E.A. Autoradiographic localization of hormone-concentrating cells in the brain of the female rhesus monkey. J. Comp. Neurol. 170 3 (1976) 279-293
241. Palmer A.A., Moyer M.R., Crabbe J.C., and Phillips T.J. Initial sensitivity, tolerance and cross-tolerance to allopregnanolone-and ethanol-induced hypothermia in selected mouse lines. Psychopharmacology 162 (2002) 313-322
242. Panesar S.K., Bandiera S.M., and Abbott F.S. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat. Drug Metab. Dispos. 24 (1996) 619-627
243. Panzica G.C., and Melcangi R.C. Steroids and the Nervous System (2004), Annals of New York Academy of Science 1007
244. Park-Chung M., Malayev A., Purdy R.H., Gibbs T.T., and Farb D.H. Sulfated and unsulfated steroids modulate ã-aminobutyric acid receptor A function through distinct sites. Brain Res. 830 (1999) 72-87
245. Patchev V.K., Hassan A.H., Holsboer D.F., and Almeida O.F. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15 (1996) 533-540
246. Paul S.M., and Purdy R.H. Neuroactive steroids. Faseb J. 6 (1992) 2311-2322
247. Payne A.H., and Hales D.B. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr. Rev. 25 (2004) 947-970
248. Pearlstein T.B. Hormones and depression: What are the facts about premenstrual syndrome, menopause, and hormone replacement therapy?. Am. J. Obstet. Gynecol. 173 (1995) 646-653
249. Persengiev S., Kanchev L., and Vezenkova G. Circadian patterns of melatonin, corticosterone, and progesterone in male rats subjected to chronic stress: Effect of constant illumination. J. Pineal Res. 11 (1991) 57-62
250. A receptor by depressant barbiturates and pregnane steroids. Br. J. Pharmacol. 94 (1988) 1257-1269
251. Poletti A., Coscarella A., Negri-Cesi P., Colciago A., Celotti F., and Martini L. 5 alpha-Reductase isozymes in the central nervous system. Steroids 63 (1998) 246-251
252. Poór V., Juricskay S., Gáti A., Osváth P., and Tényi T. Urinary steroid metabolites and 11 â-hydroxysteroid dehydrogenase activity in patients with unipolar recurrent major depression. J. Affect. Disord. 81 (2004) 55-59
253. Pouliot W.A., Handa R.J., and Beck S.G. Androgen modulates N-methyl-D-aspartate-mediated depolarization in CA1 hippocampal pyramidal cells. Synapse 23 (1996) 10-19
254. Price J.L. Comparative aspects of amygdala connectivity. Ann. N. Y. Acad. Sci. 985 (2003) 50-58
255. Pritchard III P.B., Wannamaker B.B., Sagel J., Nair R., and DeVillier C. Endocrine function following complex partial seizures. Ann. Neurol. 14 (1983) 27-32
256. Pryce C.R., Ruedi-Bettschen D., Dettling A.C., Weston A., Russig H., Ferger B., and Feldon J. Long-term effects of early-life environmental manipulations in rodents and primates: Potential animal models in depression research. Neurosci. Biobehav. Rev. 29 (2005) 649-674
257. Purdy R.H., Moore Jr. P.H., Rao P.N., Hagino N., Yamaguchi T., Schmidt P., Rubinow D.R., Morrow A.L., and Paul S.M. Radioimmuno-assay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma. Steroids 55 (1990) 290-296
258. Purdy R.H., Morrow A.L., Moore P.H., and Paul S.M. Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. USA 88 (1991) 4553-4557
259. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol 32 3 (1972) 281-294
260. Rang H., Dale M., and Ritter J. Pharmacology (1995), Churchill Livingstone, Edinburgh 512-561
261. Rannevik G., Jeppsson S., Johnell O., Bjerre B., Laurell-Borulf Y., and Svanberg L. A longitudinal study of the perimenopausal transition: Altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 21 (1995) 103-113
262. Ravizza T., Friedman L.K., Moshé S.L., and Velíšková J. Sex differences in GABA(A)ergic system in rat substantia nigra pars reticulata. Int. J. Dev. Neurosci. 21 (2003) 245-254
263. Reddy D.S. Role of neurosteroids in catamenial epilepsy. Epilepsy Res. 62 (2004) 99-118
264. Reddy D.S., and Rogawski M.A. Chronic treatment with the neuroactive-steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself. J. Pharmacol. Exp. Ther. 295 (2000) 1241-1248
265. Reddy D.S., and Rogawski M.A. Stress-induced deoxycorticosterone-derived neurosteroids modulate GABAA receptor function and seizure susceptibility. J. Neurosci. 22 (2002) 3795-3805
266. Reibel S., Andre V., Chassagnon S., Andre G., Marescaux C., Nehlig A., and Depaulis A. Neuroprotective effects of chronic estradiol benzoate treatment on hippocampal cell loss induced by status epilepticus in the female rat. Neurosci. Lett. 281 (2000) 79-82
267. Renaud L.P., and Hopkins D.A. Amygdala afferents from the mediobasal hypothalamus: An electrophysiological and neuroanatomical study in the rat. Brain Res. 121 2 (1977) 201-213
268. Resko J.A., Stadelman H.L., and Handa R.J. Control of 5α-reduction of testosterone in neuroendocrine tissues of female rats. Biol. Reprod. 34 (1986) 870-877
269. Rhodes M.E., and Frye C.A. Androgens in the hippocampus can alter, and be altered by, ictal activity. Pharmacol. Biochem. Behav. 78 (2004) 483-493
270. Rhodes M.E., and Frye C.A. Progestins in the hippocampus of female rats have antiseizure effects in a pentylenetetrazole seizure model. Epilepsia 45 (2004) 1531-1538
271. Rittmaster R.S., Leopold C.A., and Thompson D.L. Androgen glucuronyl transferase activity in rat liver, evidence for the importance of hepatic tissue in 5 á-reduced androgen metabolism. J. Steroid Biochem. 33 (1989) 1207-1212
272. Robel P., Bourreau E., Corpechot C., Dang D.C., Halberg F., Clarke C., Haug M., Schlegel M.L., Synguelakis M., and Vourch C. Neurosteroids: 3 Beta-hydroxy-delta 5-derivatives in rat and 501 monkey brain. J. Steroid Biochem. 27 (1987) 649-655
273. Romeo R.D., Lee S.J., Chhua N., McPherson C.R., and McEwen B.S. Testosterone cannot activate an adult-like stress response in prepubertal male rats. Neuroendocrinology 79 (2004) 125-132
274. Romeo R.D., Lee S.J., and McEwen B.S. Differential stress reactivity in intact and ovariectomized prepubertal and adult female rats. Neuroendocrinology 80 (2004) 387-393
275. Rosciszewska D. The course of epilepsy in girls at the age of puberty. Neurol. Neurochir. Pol. 9 (1975) 597-602
276. Rosciszewska D. Menopause in women and its effects on epilepsy. Neurol. Neurochir. Pol. 12 (1978) 315-319
277. Rosenbrock H., Hagemeyer C.E., Singec I., Knoth R., and Volk B. Testosterone metabolism in rat brain is differentially enhanced by phenytoin-inducible cytochrome P450 isoforms. J. Neuroendocrinol. 11 (1999) 597-604
278. Sallusto L., and Pozzi O. Relations between ovarian activity and the occurrence of epileptic seizures: Data on a clinical case. Acta. Neurol. 19 (1964) 673-681
279. Sanchez M.M., Ladd C.O., and Plotsky P.M. Early adverse experience as a developmental risk factor for later psychopathology: Evidence from rodent and primate models. Dev. Psychopathol. 13 (2001) 419-449
280. Sanchez P., Torres J.M., and Ortega E. Effects of dihydrotestosterone on brain mRNA levels of steroid 5alpha-Reductase isozymes in early postnatal life of rat. Neurochem. Res. 30 (2005) 577-581
281. Sanchez P., Torres J.M., Del Moral R.G., and Ortega E. Effects of testosterone on brain mRNA levels of steroid 5alpha-Reductase isozymes in early postnatal life of rat. Neurochem. Int. 49 (2006) 626-630
282. Sanne J.L., and Krueger K.E. Expression of cytochrome P450 side chain cleavage enzyme 514 and 3_-hydroxysteroid dehydrogenase in the rat central nervous system: A study by 515 polymerase chain reaction and in situ hybridization. J. Neurochem. 65 (1995) 528-536
283. Schaeffer C., and Aron C. Stress-related effects on the secretion of progesterone by the adrenals in castrated male rats presented to a stimulus male. Involvement of oestrogen. Acta. Endocrinol. 114 (1987) 440-445
284. Schmidt D., Canger R., and Avanzini G. Change of seizure frequency in pregnant epileptic women. J. Neurol. Neurosurg. Psychiatry 46 (1985) 751-755
285. Schmitz C., Rhodes M.E., Bludau M., Kaplan S., Ong P., Ueffing I., Vehoff J., Korr H., and Frye C.A. Depression: Reduced number of granule cells in the hippocampus of female, but not male, rats due to prenatal restraint stress. Mol. Psychiatry 7 (2002) 810-813
286. Schwartz-Giblin S., Korotzer A., and Pfaff D.W. Steroid hormone effects on picrotoxin-induced seizures in female and male rats. Brain Res. 476 (1989) 240-247
287. Sherwin B.B., and Gelfand M.M. A prospective one-year study of estrogen and progestin in postmenopausal women: Effects on clinical symptoms and lipoprotein lipids. Obstet. Gynecol. 73 (1989) 759-766
288. Selye H. A syndrome produced by diverse nocuous agents. Nature 138 (1936) 32-33
289. Selye H. The antagonism between anesthetic steroid hormones and pentamethylenetetrazol (Metrazol). J. Lab. Clin. Med. 27 (1941) 1051-1053
290. Serra M., Sanna E., Concas A., Foddi C., and Biggio G. Foot shock stress enhanced the increase of [35 S] TBPS binding in the rat cerebral cortex and the convulsions induced by isoniazid. Neurochem. Res. 16 (1991) 17-22
291. Sharf M., Sharf B., Bental E., and Kuzminsky T. The electroencephalogram in the investigation of anovulation and its treatment by clomiphene. Lancet 1 (1969) 750-753
292. Sherwin B.B. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J. Affect. Disord. 14 (1988) 177-187
293. Shorvon S.D. The epidemiology and treatment of chronic and refractory epilepsy. Epilepsia 37 Suppl. 2 (1996) S1-S3
294. Shughrue P.J., Lane M.V., and Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol. 388 (1997) 507-525
295. Sieghart W. Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacol. Rev. 47 (1995) 181-234
296. Silva A.J., Stevens C.F., Tonegawa S., and Wang Y. Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science 257 (1992) 201-206
297. Silverman A.J., Asarian L., Khalil M., and Silver R. GnRH, brain mast cells and behavior. Prog. Brain Res. 141 (2002) 315-325
298. Simerly R.B., Chang C., Muramatsu M., and Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: An in situ hybridization study. J. Comp. Neurol. 294 (1990) 76-95
299. Simon R.P., Aminoff M.J., and Benowitz N.L. Changes in plasma catecholamines after tonic-clonic seizures. Neurology 34 (1984) 255-257
300. Slaunwhite Jr. W.R., and Sandberg A.A. Metabolism of 4-C 14-testosterone in human subjects. III. Fate of androsterone and etiocholanolone. J. Clin. Endocrinol. Metab. 18 (1958) 1056-1066
301. Smith C.C., and McMahon L.L. Estradiol-induced increase in the magnitude of long-term potentiation is prevented by blocking NR2B-containing receptors. J. Neurosci. 26 (2006) 8517-8522
302. Spiegel E., and Wycis H. Anticonvulsant effects of steroids. J. Lab. Clin. Med. 30 (1945) 947-953
303. Stitt S.L., and Kinnard R.J. The effect of certain progestins and estrogen on the threshold of electrically-induced seizure patterns. Neurology 18 (1968) 213-216
304. Stoffel-Wagner B., Bauer J., Flugel D., Brennemann W., Klingmuller D., and Elger C.E. Serum sex hormones are altered in patients with chronic temporal lobe epilepsy receiving anticonvulsant medication. Epilepsia 39 (1998) 1164-1173
305. Summer B.E., and Fink G. Estrogen increases the density of 5-hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat. J. Steroid Biochem. Mol. Biol. 54 (1995) 15-20
306. Sundström I., Ashbrook D., and Bäckström T. Reduced benzo-diazepine sensitivity in patients with premenstrual syndrome: A pilot study. Psychoneuroendocrinology 22 (1997) 25-38
307. Sundström I., Andersson A., Nyberg S., Ashbrook D., Purdy R.H., and Bäckström T. Patients with premenstrual syndrome have a different sensitivity to a neuroactive-steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67 (1998) 126-138
308. Sutula T., and Ockuly J. Kindling, spontaneous seizures, and the consequences of epilepsy: More than a model. In: Pitkanen A., Schwartzkroin P., and Moshe S. (Eds). Models of Seizures and Epilepsy (2005), Elsevier, Amsterdam 395-406
309. Taher T.R., Salzberg M., Morris M.J., Rees S., and O'Brien T.J. Chronic low-dose corticosterone supplementation enhances acquired epileptogenesis in the rat amygdale kindling model of TLE. Neuropsychopharmacology 30 (2005) 1610-1616
310. Tasker J.G., and Dudek F.E. Electrophysiology of GABA-mediated synaptic transmission and possible roles in epilepsy. Neurochem. Res. 16 (1991) 251-262
311. Tauboll E., Lundervold A., and Gjerstad L. Temporal distribution of seizures in epilepsy. Epilepsy Res. 8 (1991) 153-165
312. Tauck D.L., and Nadler J.V. Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J. Neurosci. 5 (1985) 1016-1022
313. Tausk M. Androgens and anabolic steroids. In: Parnham M.J., and Bruinvels J. (Eds). Discoveries in Pharmacology; Haemodynamics, Hormones and Inflammation Vol. 2 (1984), Elsevier, Amsterdam 307-320
314. Tominaga K., Yamauchi A., Shuto Y., Niizeki M., Makino K., Oishi R., and Kataoka Y. Ovariectomy aggravates convulsions and hippocampal gamma-aminobutyric acid inhibition induced by cyclosporin A in rats. Eur. J. Pharmacol. 430 (2001) 243-249
315. Torres J.M., and Ortega E. Differential regulation of steroid 5alpha-Reductase isozymes expression by androgens in the adult rat brain. Faseb J. 17 (2003) 1428-1433
316. Torres J.M., and Ortega E. Alcohol intoxication increases allopregnanolone levels in female adolescent humans. Neuropsychopharmacology 28 (2003) 1207-1209
317. Torres J.M., and Ortega E. Alcohol intoxication increases allopregnanolone levels in male adolescent humans. Psychopharmacology 172 (2004) 352-355
318. Torres J.M., and Ortega E. Steroid 5alpha-Reductase isozymes in the adult female rat brain: Central role of dihydrotestosterone. J. Mol. Endocrinol. 36 (2006) 239-245
319. Torres J.M., Ruiz E., and Ortega E. Effects of CRH and ACTH administration on plasma and brain neurosteroid levels. Neurochem. Res. 26 (2001) 555-558
320. Trimble M.R. Serum prolactin in epilepsy and hysteria. Br. Med. J. 2 (1978) 1682
321. Turner D.M., Ransom R.W., Yang J.S., and Olsen R.W. Steroid anesthetics and naturally occurring analogs modulate the ã-aminobutyric acid receptor complex at a site distinct from barbiturates. J. Pharmacol. Exp. Ther. 248 (1989) 960-966
322. Turner J.P., and Simmonds M.A. Modulation of the GABAA receptor complex by steroids in slices of rat cuneate nucleus. Br. J. Pharmacol. 96 (1989) 409-417
323. Turner W.A. Epilepsy: Chapter 3. A Study of the Idiopathic Disease (1907), MacMillan, London, UK 41-64
324. Turski W.A., Cavalheiro E.A., Schwarz M., Czuczwar S.J., Kleinrok Z., and Turski L. Limbic seizures produced by pilocarpine in rats: Behavioural, electroencephalographic and neuropathological study. Behav. Brain. Res. 9 (1983) 315-335
325. Tuunanen J., Halonen T., and Pitkanen A. Status epilepticus causes selective regional damage and loss of GABAergic neurons in the rat amygdaloid complex. Eur. J. Neurosci. 8 (1996) 2711-2725
326. Twyman R.E., and Macdonald R.L. Neurosteroid regulation of GABAA receptor single-channel kinetic properties of mouse spinal cord neurons in culture. J. Physiol. 456 (1992) 215-245
327. Ukena K., Usui M., Kohchi C., and Tsutsui K. Cytochrome P450 side-chain cleavage enzyme in the cerebellar Purkinje neuron and its neonatal change in rats. Endocrinology 139 (1998) 137-147
328. Ukena K., Honda Y., Inai Y., Kohchi C., Lea R.W., and Tsutsui K. Expression and activity of 517 3_hydroxysteroid dehydrogenase/_5-4-isomerase in different regions of the avian brain. Brain Res. 140 2 (1999) 536-542
329. Ukena K., Kohchi C., and Tsutsui K. Expression and activity of 3_-hydroxysteroid dehydrogenase/520_5-_4-isomerase in the rat Purkinje neuron during neonatal life. Endocrinology 521140 (1999) 805-813
330. Van Luijtelaar G., Budziszewska B., Jaworska-Feil L., Ellis J., Coenen A., and Lason W. The ovarian hormones and absence epilepsy: A long term EEG study and pharmacological effects in a genetic absence epilepsy model. Epilepsy Res. 46 (2001) 225-239
331. Van Luijtelaar G., Budziszewska B., Tetich M., and Lason W. Finasteride inhibits the progesterone-induced spike-wave discharges in a genetic model of absence epilepsy. Pharmacol. Biochem. Behav. 75 (2003) 889-894
332. Vazquez D.M., and Akil H. Pituitary-adrenal response to ether vapor in the weanling animal: Characterization of the inhibitory effect of glucocorticoids on adrenocorticotropin secretion. Pediatr. Res. 34 (1993) 646-653
333. Velasco M.E., and Taleisnik S. Effects of the interruption of amygdaloid and hippocampal afferents to the medial hypothalamus on gonadotrophin release. J. Endocrinol. 51 (1971) 41-55
334. Velíšek L., Velíková J., Etgen A.M., Stanton P.K., and Moshé S.L. Region-specific modulation of limbic seizure susceptibility by ovarian steroids. Brain Res. 842 (1999) 132-138
335. Velíšek L., Velíšková J., Giorgi F.S., and Moshé S.L. Sex-specific control of flurothyl-induced tonic-clonic seizures by the substantia nigra pars reticulate during development. Exp. Neurol. 201 (2006) 203-211
336. Velíšková J., and Moshé S.L. Sexual dimorphism and developmental regulation of substantia nigra function. Ann. Neurol. 50 (2001) 596-601
337. Velíšková J., Velíšek L., Galanopoulou A.S., and Sperber E.F. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 41 (2000) 30-35
338. Viau V. Functional cross-talk between the hypothalamic-pituitary-gonadal and -adrenal axes. J. Neuroendocrinol. 14 (2002) 506-513
339. Vincens M., Li S.Y., and Pelletier G. Inhibitory effect of 5 beta-pregnan-3 alpha-o1-20-one on gonadotropin-releasing hormone gene expression in the male rat. Eur. J. Pharmacol. 260 (1994) 157-162
340. Voigt L.F., Weiss N.S., Chu J., Daling J.R., McKnight B., and van Belle G. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet 338 (1991) 274-277
341. Vongher J.M., and Frye C.A. Progesterone in conjunction with estradiol has neuroprotective effects in an animal model of neurodegeneration. Pharmacol. Biochem. Behav. 64 (1999) 777-785
342. Wang M., Bäckström T., Sundström I., Wahlström G., Olsson T., Zhu D., Johansson I.M., Björn I., and Bixo M. Neuroactive-steroids and central nervous system disorders. Int. Rev. Neurobiol. 46 (2001) 421-459
343. Weiland N.G., Orikasa C., Hayashi S., and McEwen B.S. Distribution and hormone regulation of estrogen receptor immunoreactive cells in the hippocampus of male and female rats. J. Comp. Neurol. 388 (1997) 603-612
344. Weinstock M. Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Prog. Neurobiol. 65 (2001) 427-451
345. Weizman R., Dagan E., Snyder S.H., and Gavish M. Impact of pregnancy and lactation on GABAA receptor and central-type and peripheral-type benzodiazepine receptors. Brain Res. 752 (1997) 307-314
346. Wenzel R.R., Bartel T., Eggebrecht H., Philipp T., and Erbel R. Central-nervous side effects of midazolam during transesophageal echocardiography. J. Am. Soc. Echocardiogr. 15 (2002) 1297-1300
347. Whitehead M.I. The effects of oestrogens and progestogens on the postmenopausal endometrium. Maturitas 1 (1978) 87-98
348. Wihlbäck A.C., Nyberg S., Bäckström T., Bixo M., and Sundström-Poromaa I. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women. Psychoneuroendocrinology 30 (2005) 38-50
349. Wiklund I., Karlberg J., and Mattsson L.A. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controlled study. Am. J. Obstet. Gynecol. 168 (1993) 824-830
350. Wilson M.A. Influences of gender, gonadectomy, and estrous cycle on GABA/BZ receptors and benzodiazepine response in rats. Brain Res. Bull. 29 2 (1992) 165-172
351. Wong M., Thompson T.L., and Moss R.L. Nongenomic actions of estrogen in the brain: Physiological significance and cellular mechanisms. Crit. Rev. Neurobiol. 10 (1996) 189-203
352. Woolley D.E., and Timiras P.S. The gonad-brain relationship Effects of female sex hormones on electroshock convulsions in the rat. Endocrinology 70 (1962) 196-209
353. Woolley D.E., Tamiras P.S., Rosenweig M.R., Krech D., and Bennett E.L. Sex and strain in electroshock convulsion of the rat. Nature 190 (1961) 15-516
354. Yu R., and Ticku M.J. Chronic neurosteroid treatment produces functional heterologous uncoupling at the _-aminibutyric acid type A benzodiazepine receptor complex in mammalian cortical neurons. Mol. Pharmacol. 47 (1995) 603-610
355. Zhang Z., Olland A.M., Zhu Y., Cohen J., Berrodin T., Chippari S., Appavu C., Li S., Wilhem J., Chopra R., Fensome A., Zhang P., et al. Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget. J. Biol. Chem. 280 (2005) 28468-28475
356. Zhu D., Birzniece V., Bäckström T., and Wahlström G. Dynamic aspects of acute tolerance to allopregnanolone evaluated using anaesthesia threshold in male rats. Br. J. Anaesth. 93 (2004) 560-567